Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Conagra is showing signs of a turnaround with improving shipment volumes, organic sales growth, and a rising market share in ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

PRNewswire Bangalore Karnataka [India] 3 New York-based VJ Group announced the launch of its newest venture VJ Bio a biotech ...

Q4 2024 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsAnoori Naughton - Senior Director of ...

NextGen Healthcare, a leading provider of innovative healthcare technology, today announced that the NextGen® Behavioral Health Suite is ranked #1 Behavioral Health solution by KLAS for the second ...

Applause, a global provider of digital quality and crowd-sourced testing solutions, today announced the expansion of its partnership with Webex by Cisco, a leading provider of collaboration ...

NAD+ IonToPatch – Utilizing iontophoresis, a non-invasive transdermal drug delivery system that uses a voltage gradient to increase skin permeability, allowing for effective NAD+ absorption. The latex ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter ...